A Study of IMC-1121B (Ramucirumab) in Colorectal Cancer

ABSTRACT: The purpose of this study is to test how long participants with colorectal cancer live without progressive disease when being treated with IMC-1121B (ramucirumab) and the modified FOLFOX-6 chemotherapy.

DISEASE(S): Colorectal Carcinoma,Metastatic Colorectal Cancer,Cáncer Colorrectal Metastásicometastatic Colorectal Cancer,Colon Cancer,Colorectal Neoplasms

PROVIDER: 2069386 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR